Commons Capital’s Medifast MED Stock Holding History

Commons Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59M	Buy	149,916 +111,916	+295%	+$1.29M	1.11%	20
2026 Q1	$387K	Hold	38,000	–	–	0.32%	54
2025 Q4	$406K	Hold	38,000	–	–	0.27%	66
2025 Q3	$519K	Hold	38,000	–	–	0.34%	58
2025 Q2	$534K	Hold	38,000	–	–	0.4%	52
2025 Q1	$512K	Hold	38,000	–	–	0.47%	49
2024 Q4	$670K	Buy	38,000 +10,563	+38%	+$196K	0.61%	39
2024 Q3	$525K	Hold	27,437	–	–	0.58%	33
2024 Q2	$599K	Buy	+27,437	New	+$731K	0.72%	30
2023 Q4	–	Sell	-4,200	Closed	-$314K	–	60
2023 Q3	$314K	Buy	+4,200	New	+$373K	0.54%	38

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Commons Capital's MED Position: Q2 2026 in Review

Commons Capital increased its Medifast (MED) stake by 295% in Q2 2026, buying an estimated $1.29M and bringing the position to 149,916 shares worth $1.59M. The position accounts for 1.11% of the portfolio, ranked #20.

Commons Capital first reported a position in MED in Q3 2023 and has held it in 10 quarters since. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Commons Capital held 149,916 shares of Medifast worth $1.59M as of Q2 2026.
Commons Capital bought 111,916 Medifast shares in Q2 2026, an estimated $1.29M.
Medifast made up 1.11% of Commons Capital's portfolio in Q2 2026, its #20 holding.
Commons Capital first reported a position in Medifast in Q3 2023 and has held it in 10 quarters since.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Commons Capital's 13F filing for Q2 2026, filed 30 Jul 2026.